Welcome!

Premium Advice
- My Services
- None
- Other Services
- Champion Funds
- Duke Street
- Global Gains
- Hidden Gems
- Income Investor
- Inside Value
- Million Dollar Portfolio
- Motley Fool Options
- Motley Fool Pro
- Pay Dirt
- Ready-Made Millionaire
- Rule Breakers
- Rule Your Retirement
- Stock Advisor
- *Get a Fool Credit Card

Help Join Now or

Updated: 12/3/2009 4:02 PM					Sponsored by:
	DOW	10366.15	-86.53	-0.83%
	S&P 500	1099.92	-9.32	-0.84%
	NASD	2173.14	-11.89	-0.54%

Premarket roundup: Nasdaq OMX, Myriad Genetics

By Associated Press
July 1, 2009 | Comments (0)

Recs

0

Among the premarket stories for Wednesday, July 1, from AP Financial News:

NEW YORK (AP) _ An analyst cut his rating on Nasdaq OMX Group Inc. to "Hold" from "Buy," citing its current valuation and a cautious outlook for the broader exchange operator sector.

NEW YORK (AP) _ Shares of Myriad Genetics Inc. plunged in premarket trading after the company forecast disappointing revenue from its molecular diagnostics business, which provides almost all its revenue.

NEW YORK (AP) _ One analyst kept a "Hold" rating on Sealy Corp. shares after the mattress maker reported results that met expectations. A second analyst said revenue trends seem to have stabilized.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

DocumentId: 932449, ~/Articles/ArticleHandler.aspx, 12/4/2009 12:19:21 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.